1Victor M Ropper AH.Adams and victor’s principles of neurology,seventh edi[M].北京:科学出版社,2001.1487—1488.
2Kokontis L, Gutmann L. Current treatment of neuromuscular diseases. Arch Neurol, 2000,57:939-943.
3Mastaglia FL, Phillips BA, Zilko P. Treatment of inflammatory myopathies. Muscle Nerve, 1997,20 : 651-664.
4Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med, 1975,292 : 344-347.
5Milanov I, Ishpekova B. Differential diagnosis of chronic idiopathic polymyositis and neuromyositis. Electromyogr Clin Neurophysiol,1998:38:183-187.
6Roux S, Seelig HP, Meyer O. Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis. J Rheumatol, 1998,25 : 395-396.
7C Schneider, Y Matsumoto. Experimental autoimmunr myositis in the Lewis rat: lack of spontaneous T-cell apoptosis and therapeutic response to glucocorticosteroid application [ J ]. Journal of Neuroimmunology, 2000, ( 107 ) : 83-87.
8Kuniko Kohyama, Yoh Matsumoto. C-protein in the skeletal muscle induces severe autoimmue polymyositis in Lewis rats [ J]. Journal of Neuroimmunology, 1999, (98) : 130-135.
9Takashi Kojima, Naoyuki Tanuma. Myosin-induced autoimmune polymyositis in the rat[J]. Journal of Neurological Sciences, 1997,(151) : 141-148.
